TRIM33 and chronic myelomonocytic leukemia: TIF1γ was reported to be downregulated in a subset of chronic myelomonocytic leukemia (CMLL) patients (93, 99), and tif1gΔ/Δ mice were confirmed to develop a CMML-like myeloproliferative disease with monocytic features.